Acasti Pharma Inc.
Acasti Pharma Inc. (ACST) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 2 transactions totaling $1.3M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Sep 25, 2023 involved a purchase of 676,371 shares valued at $1.3M.
ACST Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Kavuru Vimal | Executive | Purchase | 676,371 | $1.85 | $1.3M | Large |
| Aug 31, 2023 | Olds Donald | Executive | Purchase | 381 | $2.05 | $781 |
ACST Insider Activity Summary
Who Is Buying ACST Stock?
No significant insider buying has been recorded for ACST in the recent period.
Who Is Selling ACST Stock?
No significant insider selling has been recorded for ACST in the recent period.
Is Acasti Pharma Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACST is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ACST Frequently Asked Questions
Understanding ACST Insider Activity
Insider trading at Acasti Pharma Inc. (ACST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading ACST stock, having executed 2 transactions in the past 90 days. The most active insider is Vimal Kavuru (Executive), who has made 1 transactions totaling $1.3M.
Related Tools
Track Acasti Pharma Inc. Insider Activity
Get notified when executives and directors at ACST file new Form 4 transactions